Back to top

Image: Bigstock

Zacks Value Investor Highlights: Occidental, Anadarko, Avid, SYNNEX and j2 Global

Read MoreHide Full Article

For Immediate Release

Chicago, IL – May 3, 2019 – Zacks Value Investor is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: (

3 Tips for Beating a Buffett-Beating Portfolio

Welcome to Episode #139 of the Value Investor Podcast.

Every week, Tracey Ryniec, the editor of Zacks Value Investor portfolio, shares some of her top value investing tips and stock picks.

This week is the Berkshire Hathaway annual meeting in Omaha.

Usually, it’s a lovefest between Warren Buffett and the thousands of shareholder-fans but Barron’s recently pointed out that Berkshire’s stock (BRK.B - Free Report) has been under-performing the S&P 500 for the last 5, 10 and 15 years.

Berkshire is also sitting on $110 billion in cash, which isn’t doing much for the stock either.

Just this week, it was revealed that Berkshire had pledged $10 billion in an investment for Occidental (OXY - Free Report)  to buy Anadarko , which is now the subject of a hostile bid with Chevron.

But the $10 billion is a drop in the cash bucket. What will they do with the other $100 billion?

All value investors are struggling in a market where growth stocks are king, but there are ways value investors can do better than Warren Buffett and his investing lieutenants.

3 Tips for Building a Better Portfolio

1.       Think Small

Berkshire Hathaway is too big now. Buffett has billions to invest. He can’t mess around with a bunch of small cap companies.

But you can.

Avid Technology (AVID - Free Report)  is the platform that powers film, television and music. It has a market cap of just $319 million. It’s cheap, with a forward P/E of only 11.3.

2.       Think Technology

Warren Buffett has mostly eschewed technology companies, with IBM and Apple being the exceptions.

But the rest of us shouldn’t.

There are plenty of technology stocks that are also values right now.

SYNNEX (SNX - Free Report)  is one of those. This technology services company has a price-to-sales ratio of just 0.3.

Shareholders also get a dividend, currently yielding 1.5%.

3.       Think Digital

Warren Buffett has been a big fan of newspapers in the past, mostly for their amazing advertising moat in the classified ads.

But the Internet destroyed that moat and replaced it with digital media using display advertising.

Now, subscriptions are king and j2 Global (JCOM - Free Report)  is trying to get in on the changing digital media landscape. It operates a bunch of sites, including AskMen, and along with Everyday Health.

It is still cheap, with a forward P/E of just 12.9.

What else should you know about building a Buffett-beating portfolio?

Listen to this week’s episode to find out.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%+119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Tracey Ryniec is the Value Stock Strategist for She is also the Editor of the Insider Trader and Value Investor services. You can follow her on twitter at @TraceyRyniec and she also hosts the Zacks Market Edge Podcast on iTunes.

About Zacks is a property of Zacks Investment Research, Inc., which was formed in 1978. The later formation of the Zacks Rank, a proprietary stock picking system; continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros.  In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time!  Click here for your free subscription to Profit from the Pros.

Follow us on Twitter:

Join us on Facebook:

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.